Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 29 Sep 2017 |
2 | Reply to Exam Report (MIS-R) | 20 Dec 2017 |
3 | Authorization Letter | 20 Sep 2019 |
4 | Journal Copy | 12 Dec 2019 |
5 | TM-O(NOTICE OF OPPOSITION) | 23 Jan 2020 |
6 | Annexure -1 under rule 46 | 11 Nov 2020 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 11 Nov 2020 |
1 | Hearing Notice (Show Cause) | 8595026 | 4303327 | 15 Jul 2019 |
2 | Tribunal Accepted Notice for : 3647346 | 9008330 | 4423329 | 27 Sep 2019 |
3 | Opposition Notice | 9680104 | 4757704 | 31 Jan 2020 |
4 | Opposition Counter Statement | 10169510 | 4921612 | 15 Jul 2020 |
Trademark was applied on 29 September 2017 with IP India.
Proprietor of Dabixil is INTAS PHARMACEUTICALS.
Class(es) in which the trademark was applied to is 5.
Status of Dabixil is Opposed.
Application number alloted to the trademark is 3647346.
Y. J. Trivedi & Co is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD